
Bladder cancer and the 2023 cisplatin shortage
The Bladder Cancer Advocacy Network provides insight into the ongoing cisplatin shortage.
At the Bladder Cancer Advocacy Network, we believe that patients come first. Your concerns are our concerns, and we recognize the distress caused by drug shortages, particularly in light of the ongoing
What is happening with cisplatin and bladder cancer?
On February 10, 2023, the U.S. Food and Drug Administration (FDA)
BCAN has learned that a principal supplier of the raw materials used in carboplatin and cisplatin in India temporarily suspended manufacturing of essential cancer drugs after FDA found
What are others saying about the cisplatin shortage?
Other organizations are concerned about the situation as well like the
What about bladder cancer patients?
BCAN is aware of this troubling shortage, and we are monitoring the situation closely. We will continue to collaborate with our physician community to better understand the shortage as well as alternatives for patients.
We encourage everyone in our community to learn more about their treatment options and offer
Reference
1. Sourced from the Cancer Letter, May 26, 2023. https://cancerletter.com/the-cancer-letter/20230526_2/
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.


















